David_Warren_Ellison

The Bulls aren't Quite Done Yet: Buy the dip to target 4370

Long
CME_MINI:ES1!   S&P 500 E-mini Futures
The 10-period linear regression line has crossed the 0.2,14-period Bollinger Band which is my preferred trade signal - together with the 5-period trailing Chaikin Money Flow Slope > 0.5. Go long from 4310. Target 4370.

Market Replay finds this type of crossover to be profitable 66% of the time since April 1, 2021 - despite rigid, rules-based order management. Why can't I upload code here? Pine Script...hmmm....something new to learn I guess. A discretionary approach could be better - or worse depending on your skills. Of the 4 trades I've posted using this system on /ES (linked below), 3 were profitable, and one would have been even more profitable but for a missed entry. My results for BTC and Gold have been more mixed. The one FOREX trade I attempted on the daily version of this system was successful (NOK/USD).

In general, rules for closing this trade:

1. Price moves above the 2 STDV Upper BB and a price substitute (a 2 period linear regression line) re crosses downwards (take profits)
2. Price falls below the 2 STDV Lower BB.
3. Price crosses to the upside of the 1 STDV BB and the 10-period Regression line tries to re cross to the downside.
4. The 10 period regression line crosses below the 30 period regression line.

Upside target: 4370. How did we determine this?

The test of 4280 this morning expanded the 2 STDV Bollinger Band, so the upper band is around 4370. This should be the current upside of any move before a pause (to move higher) or a drop.
Trade closed: stop reached:
Bearish flip crossover. Exit for 5 point loss.
Trade active:
looks like the bot put me back in at 4314 overnight. Off we go.
Trade closed: stop reached:
The system algo bumped me out on the 2 period linear regression recross below the 2 stdv bb upper band at 4351.75.

a 37 point zipper
Comment:
Ended up 9 points off my target. Oh well, money was made - and is being made consistently. And that's what's important.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.